首页> 外文期刊>Indian drugs >DEVELOPMENT AND CHARACTERIZATION OF SUBLINGUAL FILM CONTAININGROPINIROLE HYDROCHLORIDE
【24h】

DEVELOPMENT AND CHARACTERIZATION OF SUBLINGUAL FILM CONTAININGROPINIROLE HYDROCHLORIDE

机译:盐酸丙烯酰硼丙醇含吡咯的开发与鉴定

获取原文
获取原文并翻译 | 示例
       

摘要

In the present work films of ropinirole hydrochloride were prepared by using polymers such as hydroxy propyl methyl cellulose (HPMC E-15) and polyethylene glycol (PEG-400) as plasticizers, by a solvent casting method, for treatment of Parkinson's disease. HPMC E-15 was used as film forming agent in the range of concentration 50 mg - 600 mg and PEG-400 was used as plasticizer in the range of concentration 0.3-1.0 mL for solvent casting method. The optimized concentration of film forming agent was 400 mg and plasticizer concentration was 0.7mL. By using optimized concentration, Ropinirole Hydrochloride mouth dissolving films (MDFs) were prepared by additionof other excipients. The formulated MDFs were evaluated for different physical characteristics like uniformity of weight, thickness, folding endurance, drug content uniformity, percentage elongation, and tensile strength, disintegration, in vitro drug release studies and provided agreeable results. The FTIR and DSC studies confirmed that no physicochemical interaction in between drug and excipients accured. Mouth dissolving film of Ropinirole Hydrochloride containing HPMC E-15 as polymer showed 97.66 % drug release at 30 min. Mouth dissolving films of ropinirole hydrochloride containing HPMC E-15 showed better tensile strength (70.56 ± 0.9 g/mm2), percentage elongation (33.33 ± 2.88 %), folding endurance (168± 2.081 numbers of folds), in vitro disintegration time (35± 3.511 sec.) and thickness (0.4± 0.17 mm).
机译:通过使用羟基丙基甲基纤维素(HPMC E-15)和聚乙二醇(PEG-400)作为增塑剂,通过溶剂浇铸方法,用于治疗帕金森病的甲丙基丙基甲基纤维素(HPMC E-15)和聚乙二醇(PEG-400),制备了盐酸罗甘油的工作薄膜。 HPMC E-15用作浓度为50mg - 600mg的膜形成剂,并且PEG-400用作浓度为溶剂浇铸方法的浓度0.3-1.0ml的增塑剂。薄膜形成剂的优化浓度为400mg,增塑剂浓度为0.7ml。通过使用优化的浓度,通过另外的赋形剂加入制备盐酸甲嘧唑溶解膜(MDF)。评估配制的MDF,用于不同的物理特性,如重量,厚度,折叠耐久性,药物含量均匀性,伸长率百分比和拉伸强度,崩解,体外药物释放研究等不同的物理特性,并提供了令人愉快的结果。 FTIR和DSC研究证实,药物和赋形剂之间没有物理化学相互作用。含有HPMC E-15的甲嘧唑盐酸盐的口腔溶解膜作为聚合物在30分钟内显示出97.66%的药物释放。含有HPMC E-15的甲丙酮氢化物的口腔溶解薄膜显示出更好的拉伸强度(70.56±0.9g / mm2),伸长率(33.33±2.88%),折叠耐久性(折叠168±2.081次数),体外崩解时间(35 ±3.511秒)和厚度(0.4±0.17 mm)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号